Nasdaq
$1.22▲ 0.83%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $972,325.36Shares out 0.8M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
10- 4d agoPre-market26.10.21 21:123Ownership#●●●
Virax Biolabs Group Ltd
Monteil Clement, an executive at Virax Biolabs Group Ltd, has filed a Form 3 to report their initial beneficial ownership of company securities. This filing formalizes the disclosure of the executive's equity holdings.…more
$1.22+0.83%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.9After-hours26.10.10 05:156-KKey event
Virax Biolabs Group Ltd
Virax Biolabs is eliminating the Chief Operating Officer (COO) role and terminating Nigel McCracken as part of a corporate restructuring to streamline operations and reduce expenses. While McCracken will leave his executive position effective December 23, 2026, he will remain on the Board of Directors, and Clement Monteil has been appointed as Acting Chief Scientific Officer for a six-month term effective October 5, 2026.…more
$1.22+0.83%vs prev closeView filingShare - 9.4After-hours26.09.05 05:206-KKey event
Virax Biolabs Group Ltd
Virax Biolabs has filed a prospectus supplement to increase the maximum aggregate offering amount of ordinary shares available under its January 22, 2024, At-The-Market (ATM) offering agreement to $2,070,060.20. This increase is intended for further capital raising beyond the $3,658,152 in shares previously sold, which may result in shareholder dilution.…more
$1.22+0.83%vs prev closeView filingShare
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswireNo news collected yet. New articles will appear here.